366 related articles for article (PubMed ID: 28634198)
1. The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection.
Mahale P; Engels EA; Li R; Torres HA; Hwang LY; Brown EL; Kramer JR
Gut; 2018 Mar; 67(3):553-561. PubMed ID: 28634198
[TBL] [Abstract][Full Text] [Related]
2. The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection.
El-Serag HB; Christie IC; Puenpatom A; Castillo D; Kanwal F; Kramer JR
Aliment Pharmacol Ther; 2019 Jun; 49(11):1442-1447. PubMed ID: 30932218
[TBL] [Abstract][Full Text] [Related]
3. Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations.
Rossi C; Jeong D; Wong S; McKee G; Butt ZA; Buxton J; Wong J; Darvishian M; Bartlett S; Samji H; Yu A; Binka M; Alvarez M; Adu PA; Tyndall M; Krajden M; Janjua NZ;
J Hepatol; 2019 Dec; 71(6):1116-1125. PubMed ID: 31433302
[TBL] [Abstract][Full Text] [Related]
4. Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
Huang CF; Lai HC; Chen CY; Tseng KC; Kuo HT; Hung CH; Wang JH; Chen JJ; Lee PL; Chien RN; Yang CC; Lo GH; Tai CM; Lin CW; Kao JH; Liu CJ; Liu CH; Yan SL; Bair MJ; Lin CY; Su WW; Chu CH; Chen CJ; Tung SY; Lo CC; Cheng PN; Chiu YC; Wang CC; Cheng JS; Tsai WL; Lin HC; Huang YH; Yeh ML; Huang JF; Dai CY; Chuang WL; Tsai PC; Peng CY; Yu ML
Am J Gastroenterol; 2020 Aug; 115(8):1226-1235. PubMed ID: 32221162
[TBL] [Abstract][Full Text] [Related]
5. Incidence and predictors of cardiovascular disease, chronic kidney disease, and diabetes in HIV/HCV-coinfected patients who achieved sustained virological response.
Leone S; Prosperi M; Costarelli S; Nasta P; Maggiolo F; Di Giambenedetto S; Saracino A; Di Pietro M; Gori A
Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1511-20. PubMed ID: 27272121
[TBL] [Abstract][Full Text] [Related]
6. The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis.
Peveling-Oberhag J; Arcaini L; Bankov K; Zeuzem S; Herrmann E
J Viral Hepat; 2016 Jul; 23(7):536-44. PubMed ID: 26924533
[TBL] [Abstract][Full Text] [Related]
7. Extrahepatic manifestations of hepatitis C among United States male veterans.
El-Serag HB; Hampel H; Yeh C; Rabeneck L
Hepatology; 2002 Dec; 36(6):1439-45. PubMed ID: 12447870
[TBL] [Abstract][Full Text] [Related]
8. Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United States.
Li J; Zhang T; Gordon SC; Rupp LB; Trudeau S; Holmberg SD; Moorman AC; Spradling PR; Teshale EH; Boscarino JA; Schmidt MA; Daida YG; Lu M;
J Viral Hepat; 2018 Aug; 25(8):952-958. PubMed ID: 29478263
[TBL] [Abstract][Full Text] [Related]
9. Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden.
Younossi Z; Park H; Henry L; Adeyemi A; Stepanova M
Gastroenterology; 2016 Jun; 150(7):1599-1608. PubMed ID: 26924097
[TBL] [Abstract][Full Text] [Related]
10. High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation.
Faisal N; Mumtaz K; Marquez M; Renner EL; Lilly LB
Hepatol Int; 2015 Jan; 9(1):76-83. PubMed ID: 25788382
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era.
Wiznia LE; Laird ME; Franks AG
J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1260-1270. PubMed ID: 28252812
[TBL] [Abstract][Full Text] [Related]
12. Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study.
Butt AA; Yan P; Shaikh OS; Lo Re V; Abou-Samra AB; Sherman KE
J Hepatol; 2020 Aug; 73(2):277-284. PubMed ID: 32145260
[TBL] [Abstract][Full Text] [Related]
13. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.
Mazzaro C; Quartuccio L; Adinolfi LE; Roccatello D; Pozzato G; Nevola R; Tonizzo M; Gitto S; Andreone P; Gattei V
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835054
[TBL] [Abstract][Full Text] [Related]
14. Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis.
Cacoub P; Desbois AC; Comarmond C; Saadoun D
Gut; 2018 Nov; 67(11):2025-2034. PubMed ID: 29703790
[TBL] [Abstract][Full Text] [Related]
15. [Extrahepatic manifestations of chronic hepatitis C and their influence on response to treatment with pegylated interferon alfa-2a and ribavirin].
Fabri M; Ruzić M; Lendak D; Preveden T; Fabri I; Petrić V
Srp Arh Celok Lek; 2013; 141(5-6):320-4. PubMed ID: 23858800
[TBL] [Abstract][Full Text] [Related]
16. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
17. Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.
El-Serag HB; Kanwal F; Richardson P; Kramer J
Hepatology; 2016 Jul; 64(1):130-7. PubMed ID: 26946190
[TBL] [Abstract][Full Text] [Related]
18. Evolution of HCV associated porphyria cutanea tarda after HCV sustained virologic response by direct acting antivirals.
García-Fraile LJ; García-Buey L; Alonso Cerezo C; Sanz Sanz J; de Los Santos Gil I
Gastroenterol Hepatol; 2022 Apr; 45(4):249-255. PubMed ID: 34562521
[TBL] [Abstract][Full Text] [Related]
19. Rheumatoid factor and immunoglobulin M mark hepatitis C-associated mixed cryoglobulinaemia: an 8-year prospective study.
Cheng YT; Cheng JS; Lin CH; Chen TH; Lee KC; Chang ML
Clin Microbiol Infect; 2020 Mar; 26(3):366-372. PubMed ID: 31229596
[TBL] [Abstract][Full Text] [Related]
20. Long-term impact of certain coexisting extrahepatic unisystem and multisystem manifestations on trends in incidence of liver cirrhosis in treatment-naïve patients with chronic hepatitis C: A nested case-control study.
Wang CH; Ou SF; Tseng YT
Medicine (Baltimore); 2022 Jul; 101(29):e29697. PubMed ID: 35866797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
